Company profile for Interquim SA

PharmaCompass

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Related CompaniesRelated Companies

About

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Carrer de Joan Buscallà, 10, 08173 Sant Cugat del Vallès (Barcelona)
Telephone
Telephone
+34 935044200
youtube
YouTube

Events

Webinars & Exhibitions

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $tile1

Filename: tabs/exhibitions.php

Line Number: 43

Backtrace:

File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler

File: /var/www/html/application/models/CmnPec.php
Line: 1625
Function: view

File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create

File: /var/www/html/application/views/include/party/indexNew.php
Line: 70
Function: include

File: /var/www/html/application/views/commonNew.php
Line: 445
Function: include

File: /var/www/html/application/controllers/PharmaServices.php
Line: 4640
Function: view

File: /var/www/html/index.php
Line: 224
Function: require_once

CPhI India 2024

CPhI India 2024

Not Confirmed

envelop Contact Supplier

CPhI India 2024

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/interquim-sa-party-content-4473.pdf

    https://www.pharmacompass.com/pdf/party/content/interquim-sa-party-content-58017.pdf

    https://www.pharmacompass.com/pdf/party/content/interquim-sa-party-content-79653.pdf

DATA COMPILATION #PharmaFlow

read-more
read-more
DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   

Impressions: 5934

https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

#PharmaFlow by PHARMACOMPASS
24 Oct 2024

NEWS #PharmaBuzz

read-more
read-more
Discover our 2023 Sustainability Report
Discover our 2023 Sustainability Report

07 Oct 2024

// PRESS RELEASE

https://www.ferrer.com/sites/default/files/2024-07/Ferrer_Sustainability_Report_2023_web.pdf

PRESS RELEASE
07 Oct 2024

https://www.ferrer.com/en/Ferrer-advances-research-Progressive-Supranuclear-Palsy-PSP

PRESS RELEASE
08 Aug 2024

https://www.ferrer.com/en/Tyvaso-indications-idiopathic-pulmonary-fibrosis-progressive-pulmonary-fibrosis

PRESS RELEASE
24 May 2024

https://www.ferrer.com/en/pacientes-hipertension-pulmonar-reivindica-sopoerte-psicologico

PRESS RELEASE
21 Apr 2024

https://www.ferrer.com/en/node/19931

PRESS RELEASE
25 Mar 2024

https://www.ferrer.com/en/CDP-rates-us-among-the-leading-companies-in-the-fight-against-climate-change

PRESS RELEASE
06 Feb 2024

01

Rivastigmine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF arrow-down VMF ASMF, CA... arrow-down AUDIT
Interquim

02

Celecoxib

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Interquim

03

Olmesartan Medoxomil

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
Interquim

04

Ozenoxacin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Interquim

05

Rotigotine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Interquim

06

Sertaconazole Nitrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Interquim

07

Solifenacin Succinate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Interquim

08

Tadalafil

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
Interquim

09

Telmisartan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
Interquim

10

Tolterodine Tartrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF CN arrow-down AUDIT
Interquim
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more

01

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2012-351 - Rev 01

Status : Valid

Issue Date : 2021-07-22

Type : Chemical

Substance Number : 2591

Interquim

02

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2010-022 - Rev 00

Status : Valid

Issue Date : 2016-03-23

Type : Chemical

Substance Number : 1302

Interquim

03

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2014-295 - Rev 01

Status : Valid

Issue Date : 2022-12-19

Type : Chemical

Substance Number : 2600

Interquim

04

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2013-354 - Rev 00

Status : Valid

Issue Date : 2020-01-23

Type : Chemical

Substance Number : 2629

Interquim

05

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2013-331 - Rev 00

Status : Valid

Issue Date : 2020-01-23

Type : Chemical

Substance Number : 2630

Interquim

06

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : CEP 2019-302 - Rev 01

Status : Valid

Issue Date : 2024-05-03

Type : Chemical

Substance Number : 3014

Interquim

07

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R2-CEP 1995-011 - Rev 03

Status : Valid

Issue Date : 2022-04-05

Type : Chemical

Substance Number : 1148

Interquim

08

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2016-143 - Rev 00

Status : Valid

Issue Date : 2022-07-01

Type : Chemical

Substance Number : 2779

Interquim

09

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2015-101 - Rev 00

Status : Valid

Issue Date : 2021-04-30

Type : Chemical

Substance Number : 2606

Interquim

10

arrow
The Pharmacy Technology
Not Confirmed

Interquim SA

Certificate Numbers : R1-CEP 2010-363 - Rev 00

Status : Valid

Issue Date : 2019-02-04

Type : Chemical

Substance Number : 2154

Interquim
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Interquim SA

Registration Number : 227MF10298

Registrant's Address : Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Initial Date of Registration : 2015-12-28

Latest Date of Registration : 2020-05-12

Interquim

02

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Interquim SA

Registration Number : 226MF10031

Registrant's Address : Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Initial Date of Registration : 2014-02-05

Latest Date of Registration : 2022-08-03

Interquim

03

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Interquim SA

Registration Number : 301MF10032

Registrant's Address : Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Initial Date of Registration : 2019-07-19

Latest Date of Registration : 2019-07-19

Interquim

04

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Interquim SA

Registration Number : 230MF10089

Registrant's Address : Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Initial Date of Registration : 2018-07-20

Latest Date of Registration : 2018-07-20

Interquim

05

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Interquim SA

Registration Number : 226MF10144

Registrant's Address : Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Initial Date of Registration : 2014-07-31

Latest Date of Registration : 2015-11-19

Interquim
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-more

01

Interquim SA

Registrant Name : Bukwang Pharmaceutical Co., Ltd.

Registration Date : 2021-07-11

Registration Number : 20210711-209-J-1062

Manufacturer Name : Interquim, SA

Manufacturer Address : Joan Buscallà 10 E-08173 Sant Cugat del Vallès (Barcelona), Spain

Interquim

02

Interquim SA

Registrant Name : IMCD Korea Co., Ltd.

Registration Date : 2018-12-19

Registration Number : 20181219-210-J-289

Manufacturer Name : Interquim SA

Manufacturer Address : C/Joan Buscalla, 10 E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Interquim

03

Interquim SA

Registrant Name : Sungwoo Chemical Co., Ltd.

Registration Date : 2020-10-15

Registration Number : 473-27-ND

Manufacturer Name : Interquim SA

Manufacturer Address : c/ Joan Buscallà, 10, 08173 Sant Cugat Del Vallès (Barcelona), Spain

Interquim

04

Interquim SA

Registrant Name : Bukwang Pharmaceutical Co., Ltd.

Registration Date : 2021-12-10

Registration Number : Su403-3-ND

Manufacturer Name : Interquim, SA

Manufacturer Address : Joan Buscallà 10 E-08173 Sant Cugat del Vallès (Barcelona), Spain

Interquim

05

Interquim SA

Registrant Name : Kyungbo Pharmaceutical Co., Ltd.

Registration Date : 2020-05-04

Registration Number : Number 1673-33-ND

Manufacturer Name : Interquim, SA

Manufacturer Address : c/ Joan Buscalla, 10, 08173 Sant Cugat del Vallaes (Barcelona), Spain

Interquim

06

Interquim SA

Registrant Name : Samyang Holdings Co., Ltd.

Registration Date : 2017-12-08

Registration Number : 20170821-184-I-519-16(2)

Manufacturer Name : Interquim, SA

Manufacturer Address : c/ Joan Buscallà,10, 08173 Sant Cugat Del Vallès (Barcelona), Spain

Interquim

07

Interquim SA

Registrant Name : Shinil Pharmaceutical Co., Ltd.

Registration Date : 2017-11-27

Registration Number : 20170821-184-I-519-16(1)

Manufacturer Name : Interquim, SA

Manufacturer Address : c/ Joan Buscalla, 10, 08173 Sant Cugat del Vallaes (Barcelona), Spain

Interquim

08

Interquim SA

Registrant Name : Sungwoo Chemical Co., Ltd.

Registration Date : 2017-08-21

Registration Number : 20170821-184-I-519-16

Manufacturer Name : Interquim, SA

Manufacturer Address : c/ Joan Buscallà, 10, 08173 Sant Cugat Del Vallès (Barcelona), Spain

Interquim

09

Interquim SA

Registrant Name : Seongi Bio Co., Ltd.

Registration Date : 2016-12-29

Registration Number : Su259-4-ND

Manufacturer Name : Interquim, SA

Manufacturer Address : Joan Buscalla 10, E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Interquim

10

Interquim SA

Registrant Name : Bukwang Pharmaceutical Co., Ltd.

Registration Date : 2021-10-18

Registration Number : 20211018-209-J-1122

Manufacturer Name : Interquim, SA

Manufacturer Address : Joan Buscallà 10 E-08173 Sant Cugat del Vallès (Barcelona), Spain

Interquim
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

LISTED APIs

read-more
read-more
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

01

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

02

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

03

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

04

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

05

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

06

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

07

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

08

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

09

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmac...
Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

10

arrow
Compamed
Not Confirmed

Interquim SA

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet str...

Interquim
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KEY PRODUCTS

read-more
read-more

TOP RANKED SUPPLIER FOR:

Sponsored Ads.
full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view

Services

Discover the service capabilities from this company

KEY SERVICES

read-more
read-more

TOP RANKED SUPPLIER FOR:

TOP RANKED SUPPLIER FOR:

Process Development & Scale-Up
full-view

Inspections and registrations

Check the inspections & registration from this company

FDA

read-more
read-more

01

FDA Audited

USA

Interquim SA

City : Sant Cugat Del Valles

State :

Country/Area : ES

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-09-09

Interquim

02

FDA Audited

USA

Interquim SA

City : Sant Cugat Del Valles

State :

Country/Area : ES

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-10-11

Interquim

03

FDA Audited

USA

Interquim SA

City : Sant Cugat del Valles

State :

Country/Area : ES

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-06-02

Interquim

04

FDA Audited

USA

Interquim SA

City : Sant Cugat del Valles

State :

Country/Area : ES

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Official Action Indicated

Inspection End Date : 2016-05-06

Interquim

05

FDA Audited

USA

Interquim SA

City : Sant Cugat Del Valles

State :

Country/Area : ES

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2018-12-20

Interquim

06

FDA Audited

USA

Interquim SA

City : Sant Cugat Del Valles

State :

Country/Area : ES

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-09-27

Interquim
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Others

read-more
read-more

ABOUT THIS PAGE

Contact Interquim SA and get a quotation

Interquim SA is a supplier offers 30 products (APIs, Excipients or Intermediates).

Find a price of Rivastigmine bulk with DMF, CEP, JDMF offered by Interquim SA

Find a price of Celecoxib bulk with DMF, CEP offered by Interquim SA

Find a price of Olmesartan Medoxomil bulk with CEP, JDMF offered by Interquim SA

Find a price of Ozenoxacin bulk with DMF, JDMF offered by Interquim SA

Find a price of Rotigotine bulk with DMF, CEP offered by Interquim SA

Find a price of Sertaconazole Nitrate bulk with DMF, CEP offered by Interquim SA

Find a price of Solifenacin Succinate bulk with DMF, CEP offered by Interquim SA

Find a price of Tadalafil bulk with CEP, JDMF offered by Interquim SA

Find a price of Telmisartan bulk with CEP, JDMF offered by Interquim SA

Find a price of Tolterodine Tartrate bulk with DMF, CEP offered by Interquim SA

Find a price of Aripiprazole bulk with DMF offered by Interquim SA

Find a price of Aripiprazole Lauroxil bulk with DMF offered by Interquim SA

Find a price of Ciclopirox bulk with DMF offered by Interquim SA

Find a price of Ciclopirox Olamine bulk with CEP offered by Interquim SA

Find a price of Ferric Carboxymaltose bulk with DMF offered by Interquim SA

Find a price of Imiquimod bulk with DMF offered by Interquim SA

Find a price of Lifitegrast bulk with DMF offered by Interquim SA

Find a price of Paliperidone Palmitate bulk with DMF offered by Interquim SA

Find a price of Risperidone bulk with DMF offered by Interquim SA

Find a price of Rivastigmine Tartrate bulk with CEP offered by Interquim SA

Find a price of Roflumilast bulk with DMF offered by Interquim SA

Find a price of Edaravone bulk offered by Interquim SA

Find a price of Ferric Derisomaltose bulk offered by Interquim SA

Find a price of Lumateperone Tosylate bulk offered by Interquim SA

Find a price of Paliperidone bulk offered by Interquim SA

Find a price of Pimavanserin Tartrate bulk offered by Interquim SA

Find a price of Rasagiline Tartrate bulk offered by Interquim SA

Find a price of Tapinarof bulk offered by Interquim SA

Find a price of Torsemide bulk offered by Interquim SA

Find a price of Uridine Triphosphate Trisodium bulk offered by Interquim SA

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty